Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Investigation launched into ADMA Biologics for alleged securities fraud after stock plunge.
ADMA
$8.62
-$0.06 -0.75%

Investigation launched into ADMA Biologics for alleged securities fraud after stock plunge.

Market News
16 Apr 2026
PRNewsWire
View Source
Bearish
pluang ai news

Pomerantz LLP is investigating ADMA Biologics and some of its executives for possible securities fraud following a short report accusing the company of inflating revenue through channel stuffing and undisclosed related party sales. The report caused ADMA's stock to drop significantly, and a subsequent downgrade by Cantor Fitzgerald further pressured the share price. This investigation could lead to legal actions if misconduct is confirmed, impacting investors and the company's reputation.

More News (ADMA)

Deadline nears for investors to join class action lawsuits against BTGO, VIA, Z, and ADMA for alleged securities fraud.

Deadline nears for investors to join class action lawsuits against BTGO, VIA, Z, and ADMA for alleged securities fraud.

Law Offices of Howard G. Smith reminds investors of approaching deadlines to file lead plaintiff motions in class action lawsuits against BitGo Holdings, Via Transportation, Zillow Group, and ADMA Biologics. These lawsuits allege the companies made f...

Market News
Bearish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App